Skip to content

Released Feb 27, 2025, before the open

10-K filed Feb 27, 2025, 58 days after period end · 0001628280-25-008409

Q4 2024 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$109.89Mderived+66.9% vs Q4 2023+7.9% vs Q3 2024
Net Income-$81.68MderivedN/M vs Q4 2023N/M vs Q3 2024
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$67,891,000N/M
Operating Cash Flowderived-$55,769,000N/M
Free Cash Flowderived-$58,369,000N/M
Margins · derived
Operating margin-61.8%+126.6 pt vs Q4 2023
Net margin-74.3%+70.6 pt vs Q4 2023

What the release said

The release

Same quarter

MetricQ4 2024derived from reported figuresQ4 2023derived from reported figuresQ4 2022derived from reported figuresQ4 2021
Revenue$109.89M$65.83M$62.04M$43.96M
Net Income-$81.68M-$95.43M-$61.77M-$211.83M
EPS Diluted———-$2.22

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Zai Lab Ltd · CIK 1704292 · Engraved from SEC EDGAR